- Commentary on "Ambient air pollution and endocrinologic disorders in childhood"
-
Chae HW
- KMID: 2520504
- Ann Pediatr Endocrinol Metab.
- 2021 Sep;26(3):135-135.
- doi: 10.6065/apem.2121066edi01
-
- CITED
-
- Close
- SHARE
-
- Close
- Commentary on "Single random measurement of urinary gonadotropin concentration for screening and monitoring girls with central precocious puberty"
-
Kwon A
- KMID: 2520505
- Ann Pediatr Endocrinol Metab.
- 2021 Sep;26(3):136-137.
- doi: 10.6065/apem.2120104edi01
-
- CITED
-
- Close
- SHARE
-
- Close
- Ambient air pollution and endocrinologic disorders in childhood
-
Heo YJ, Kim HS
- KMID: 2520508
- Ann Pediatr Endocrinol Metab.
- 2021 Sep;26(3):158-170.
- doi: 10.6065/apem.2142132.066
Ambient air pollution has been proposed as an important environmental risk factor that increases global mortality and morbidity. Over the past decade, several human and animal studies have reported an... -
- CITED
-
- Close
- SHARE
-
- Close
- Diverse etiologies, diagnostic approach, and management of primary adrenal insufficiency in pediatric age
-
Yoo HW
- KMID: 2520507
- Ann Pediatr Endocrinol Metab.
- 2021 Sep;26(3):149-157.
- doi: 10.6065/apem.2142150.075
Primary adrenal insufficiency (PAI) in pediatric age is a rare, but potentially fatal condition caused by diverse etiologies including biochemical defects of steroid biosynthesis, developmental abnormalities of the adrenal gland,... -
- CITED
-
- Close
- SHARE
-
- Close
- Immobilization-induced symptomatic hypercalcemia treated with zoledronate in a child with a left ventricular assist device
-
Gün E, Kendirli T, Botan E, Uçar T, Aycan Z, Akar AR
- KMID: 2520514
- Ann Pediatr Endocrinol Metab.
- 2021 Sep;26(3):205-209.
- doi: 10.6065/apem.2040206.103
Differential diagnosis of hypercalcemia in children includes confirmation of hyperthyroidism, infection, inflammatory processes, and malignant tumors. Immobilization-induced hypercalcemia is rare in healthy individuals, although it can occur in adolescent males,... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical findings influencing time to menarche post gonadotropin-releasing hormone agonist therapy in central precocious puberty
-
Wu V, Zhao V, Issa R, Wilkes M, Wallach E, Rapaport R, Romero C, Yau M
- KMID: 2520511
- Ann Pediatr Endocrinol Metab.
- 2021 Sep;26(3):185-191.
- doi: 10.6065/apem.2040220.110
Purpose: This study aimed to evaluate the time interval to menarche after gonadotropin-releasing hormone agonist (GnRHa) treatment in females with central precocious puberty (CPP) and to identify factors contributing to... -
- CITED
-
- Close
- SHARE
-
- Close
- Myhre syndrome: the first case in Korea
-
Lim D, Kim JH, Lee J
- KMID: 2520515
- Ann Pediatr Endocrinol Metab.
- 2021 Sep;26(3):210-214.
- doi: 10.6065/apem.2040214.107
Myhre syndrome (MS) is a rare autosomal-dominant disorder characterized by short stature, intellectual disability, skeletal anomalies, restricted joint mobility, distinctive facial dysmorphism, and deafness. Early diagnosis of MS is difficult... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves’ disease
-
Lee HG, Yang EM, Kim CJ
- KMID: 2520513
- Ann Pediatr Endocrinol Metab.
- 2021 Sep;26(3):199-204.
- doi: 10.6065/apem.2142046.023
Purpose: The first-line antithyroid drug for children and adolescents with Graves’ disease (GD) is methimazole (MMI). This study evaluated the relationship between the initial MMI dose and the clinical course... -
- CITED
-
- Close
- SHARE
-
- Close
- Steroidogenic electron-transfer factors and their diseases
-
Miller WL
- KMID: 2520506
- Ann Pediatr Endocrinol Metab.
- 2021 Sep;26(3):138-148.
- doi: 10.6065/apem.2142154.077
Most steroidogenesis disorders are caused by mutations in genes encoding the steroidogenic enzymes, but work in the past 20 years has identified related disorders caused by mutations in the genes... -
- CITED
-
- Close
- SHARE
-
- Close
- Short-term efficacy of 1-month and 3-month gonadotropin-releasing hormone agonist depots in girls with central precocious puberty
-
Jeon MJ, Choe JW, Chung HR, Kim JH
- KMID: 2520509
- Ann Pediatr Endocrinol Metab.
- 2021 Sep;26(3):171-177.
- doi: 10.6065/apem.2040134.067
Purpose: Gonadotropin-releasing hormone agonist (GnRHa) has been the mainstay of central precocious puberty (CPP) treatment for decades, but few reports have compared the efficacy of 1-month and 3-month depot GnRHa... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of body mass index on peak growth hormone level after growth hormone stimulation test in children with short stature
-
Lee NY, Kim SE, Kim S, Ahn MB, Kim SH, Cho WK, Cho KS, Jung MH, Suh BK
- KMID: 2520512
- Ann Pediatr Endocrinol Metab.
- 2021 Sep;26(3):192-198.
- doi: 10.6065/apem.2040246.123
Purpose: The aim of this study is to evaluate the effect of body mass index (BMI) on peak serum growth hormone (GH) level after GH stimulation test in children with... -
- CITED
-
- Close
- SHARE
-
- Close
- Single random measurement of urinary gonadotropin concentration for screening and monitoring girls with central precocious puberty
-
Lee SY, Kim JM, Kim YM, Lim HH
- KMID: 2520510
- Ann Pediatr Endocrinol Metab.
- 2021 Sep;26(3):178-184.
- doi: 10.6065/apem.2040208.104
Purpose: The gold standard for assessing pubertal activation is the gonadotropinreleasing hormone (GnRH) stimulation test (GnRHST), which is invasive, timeconsuming, and inconvenient. This study evaluated whether a single random measurement... -
- CITED
-
- Close
- SHARE
-
- Close
